The role of patient triggered ventilation (PTV) for the newborn was assessed using a new patient triggered ventilator, the Draeger Babylog 8000, which incorporates significant improvements in both ventilator performance and the triggering system. Thirty three infants, median gestational age 30 weeks and postnatal age 2-5 days, were entered into the study to compare blood gases obtained during conventional and patient triggered ventilation. Oxygenation did not improve with PTV in the group overall but increased significantly (median change 7%) in infants greater than 28 weeks' gestation. Arterial carbon dioxide tension (Paco2) decreased during PTV in the majority of infants (median reduction 7%), this was not related to the gestational or postnatal age, but was greatest in infants previously on a low conventional ventilation rate. Blood gases (both Pao2 and Paco2) deteriorated in infants requiring the highest inspired oxygen concentration. We conclude that patient triggered ventilation is most useful in infants with mild respiratory distress.
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Patient triggered ventilation (PTV) was reintroduced as a method of respiratory support for neonates in 1986.1 Since that time there have been a series of studies which have assessed both the possible shortt-3 and long term benefits of PTV. 4 5 In the majority of infants oxygenation acutely improves on transfer from conventional ventilation to PTV1-3 but PTV fails to provide a successful method of respiratory support in infants of less than 28 weeks' gestation4 or if it is started in the first 24 hours of life.5 A predictor of failure of PTV was an asynchronous respiratory interaction, with inflation occurring either late in inspiration or even in expiration, as a result of a long trigger delay.5 All these studies have employed a mod- Recently, purpose built patient triggering ventilators have appeared. We have demonstrated that one such ventilator (Draeger Babylog 8000) has a performance superior to the SLE, with a much shorter trigger delay: a median of 80-100 ms (Draeger) compared with a median of 200-250 ms (SLE). 6 The Draeger Babylog 8000 also has the advantage of no inadvertent positive end expiratory pressure (PEEP) at high flow rates7 or the fast ventilator rates which are frequently triggered by very immature infants.8 Thus it seems likely that this ventilator could be used with success in a more varied group of infants. Our aim, therefore, was to use the Draeger ventilator to redefine the optimal role of PTV.
Methods
Infants were entered into the study when they had been stable on conventional ventilation for at least two hours and when a ventilator became available. All infants had previously been ventilated using Sechrist ventilators and had blood gases within the clinically acceptable range (pH 7-25-7-4, arterial oxygen tension (Pao2) 5 .33-9-33 kPa, arterial carbon dioxide tension (Paco2) 4-67-6-67 kPa).
The patients were then changed over to the Draeger Babylog 8000 ventilator and ventilated conventionally for one hour at the same settings as were previously in use. The ventilator was then switched into patient triggered mode for at least one hour. The Draeger Babylog 8000 utilises an airflow triggering system, a hot wire anemometer, which has the advantage of not increasing the dead space of the patient circuit. We have demonstrated that the median trigger delay of this system is between 80 and 100 ms at inflation times between 0 24 and 0 4 seconds. 6 On switching into the patient triggered mode the peak inspiratory pressure, PEEP, gas flow rate, and inspired oxygen concentration were not changed. An inflation time initially of 0-4 seconds was used, reducing in steps of 0-02 seconds, if necessary, until the spontaneous respiratory effort was no longer visibly distinct from the positive pressure inflation.
Throughout the study infants were monitored continuously using a Searle intra-arterial electrode or transcutaneous oxygen electrode. 
No significant change was found in Pao2 when blood gases were compared between the period of conventional ventilation and PTV: Pao2 increased in 17 patients, decreased in 13 and there was no change in the remaining three infants (fig 1) . Oxygenation significantly improved in infants greater than 28 weeks' gestational age (p<005), with a median (range) improvement in Pao2 of 7 (-28 to +42)%. Fifteen of the 23 infants of gestational age greater than 28 weeks had an improvement in oxygenation, compared with only two of the 10 infants less than 28 weeks gestational age (p<005). Oxygenation also significantly improved in the subgroup of infants of greater than 28 weeks' gestation who were ventilated at a rate of more than 15 breaths/minute (p<0 05). There were no significant relationships between changes in oxygenation and postnatal age, fractional inspired oxygen concentration (FiO2) or peak inspiratory pressure (table 1) .
Paco2 showed a significant decrease over the PTV study period, decreasing in 21 patients and increasing in 12 patients, median (range) change -7 (-43 to +29-4)% (p<005). This change in Paco2 was neither significantly related to gestational nor postnatal age (fig 1) . In the 12 patients whose Paco2 increased, the median ventilator rate on conventional ventilation was significantly higher than in the 21 patients in whom Paco2 decreased (p<005) (fig 2, table 2 ). No significant relationships were found between changes in Paco2 and either the peak inspiratory pressure or improved oxygen concentration (FiO2) (table 2).
The improvement in oxygenation was associated with a reduction in Paco2 in 12 patients, but a rise in Paco2 in five others. These five infants had been previously ventilated at a significantly higher rate than the rest of the study group (p<0 05). A deterioration in Pao2 was accompanied by a fall in Paco2 in nine patients (these infants were significantly less mature, but older than the rest of the study group; p<005) and a rise in Paco2 in seven others. Infants in whom there was no improvement in either Pao2 or Paco2 required a higher inspired oxygen concentration (p=0054) and peak inflating pressure than the remaining infants (table 3) . Infants whose blood gases improved on PTV were maintained on this mode for up to several days or until extubation; no complications were experienced. We have previously demonstrated that failure of oxygenation to improve after one hour is an accurate predictor of a lack of successful respiratory support by PTV.4 5 The results of this study, therefore, indicate that despite improvements in ventilator design and performance there remains a substantialproportion of infants for whom PTV is not a useful alternative to conventional ventilation. The failure to improve oxygenation in the most immature infants, the greater reduction in Paco2 at previously low ventilator rates and the combination of failure of oxygenation and increase in Paco2 in infants at the highest inspired oxygen concentration all suggest PTV is more suitable for infants with mild, not severe, respiratory distress.
